For research use only. Not for therapeutic Use.
<p style=/line-height:25px/>Ginsenoside Rc is a steroid glycoside, and triterpene saponins, found exclusively in the plant genus Panax (ginseng); have properties that inhibit or prevent tumors growth.<br>IC50 value:<br>Target:<br>in vitro: Rc reduced the proliferation and viability of 3T3-L1 preadipocytes in a dose-dependent manner. Treatment with Rc decreased the number of adipocytes and reduced lipid accumulation in maturing 3T3-L1 preadipocytes, demonstrating an inhibitory effect on lipogenesis. Rc directly induced lipolysis in adipocytes and down-regulated the expression of major transcription factors of the adipogenesis pathway, such as PPARγ and C/EBPα [1]. overexpression of catalase induced by Rc resulted in suppression of RS production in kidney human embryo kidney 293T cells (HEK293T) cells, and that oxidative stress induced activation of PI3K/Akt and inhibition of the AMPK pathway and FoxO1 phosphorylation, leading to down-regulation of catalase, a FoxO1-targeting gene. In addition, treatment of HEK293T cells with Rc resulted in cAMP-response element-binding protein (CREB)-binding protein (CBP) regulated FoxO1 acetylation [2].</p>
Catalog Number | I000421 |
CAS Number | 11021-14-0 |
Molecular Formula | C53H90O22 |
Purity | ≥95% |
Solubility | 10 mM in DMSO |
Storage | -20°C |
Reference | <p style=/line-height:25px/> <br>[2]. Kim DH, et al. Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress. Arch Pharm Res. 2014 Jun;37(6):813-20. </p> |